Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19

NCT04341493 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Concerns about safety of Hydroxychloroquine

Conditions

Coronavirus Infection

Interventions

DRUG: Nitazoxanide 500 MG
DRUG: Hydroxychloroquine

Sponsor

Hugo Mendieta Zeron